| Facing Cancer and the Fear of Death: A Psychoanalytic Perspective on Treatment
Norman Straker Publisher's Comments:
In Facing Cancer and the Fear of Death: A Psychoanalytic Perspective on Treatment, Dr. Norman Straker proposes that “death anxiety” is responsible for the American society’s failure to address costly futile care at the end of life; more specifically, doctors default on the appropriate prescription of palliative care because of this anxiety. This leads to unnecessary suffering for terminally-ill patients and their families and significant distress for physicians. To address these challenges in the culture of medical education, increased psychological support for physicians who treat dying patients is necessary. Additionally, physicians need to reach a consensus regarding the discontinuation of active treatments.
Psychoanalysts have traditionally denied the importance of death anxiety and report relatively few treatment cases of dying patients in their literature. This book offers multiple treatment reports by psychoanalysts that illustrate the effectiveness and value of a flexible approach to patients facing death. The psychoanalytic reader is expected to gain a greater level of comfort with facing death and is encouraged to consider making themselves more available to the ever-increasing population of cancer survivors. Further, psychoanalysts are encouraged to be more useful partners to the oncologists that are burdened by the irrational feelings of all parties.
Have you read this book?
Tell us what you think |
| Clinical Manual of Child and Adolescent Psychopharmacology, Second Edition
Molly McVoy and Robert L. Findling Publisher's Comments:
This new, thoroughly revised second edition of the Clinical Manual of Child and Adolescent Psychopharmacology is designed to help clinicians provide state-of-the-art care to their patients and keep up to date with the most recent research. It reflects the reality that child and adolescent psychiatry in general, and psychopharmacology in particular, are rapidly progressing fields that are advancing in multiple directions at once. Because pharmacokinetic processes in children and adolescents can vary significantly from those in adults, it is critical that clinicians have access to the latest information on indications, medications, dosages, interactions, side effects, and off-label use for the pediatric patient population. The book offers clinicians comprehensive information and a multitude of helpful features. Specifically, it: Thoroughly describes and explores those elements that are specific to pediatric psychopharmacology and make it a distinct discipline at the crossroads of child and adolescent psychiatry, pediatrics, and pharmacology. Boasts a Contributors list of leading clinician/scientists, whose insight into the latest research findings and analysis of their clinical implications enable readers to incorporate those findings into their clinical practice. Takes an evidence-based approach to controversial issues in pediatric psychopharmacology, such as attention-deficit/hyperactivity disorder (ADHD) diagnosis and its treatment with psychostimulants, as well as pediatric mood disorders, including bipolar disorder. Examines advances that have been made in understanding the long-term treatment effects of medications in pediatric populations, including the results of head-to-head medication comparison studies that have been completed since the first edition was published. Analyzes recent studies of combination therapies, so that clinicians will better understand how to treat the complex patients that they see every day. Clinicians who bought the first edition will want this revision, as will those just venturing into the pharmacological treatment of children and adolescents. Utterly current, comprehensive, and compelling, the Clinical Manual of Child and Adolescent Psychopharmacology, Second Edition, reflects the major steps that have been made toward improving the evidence-based practice of treating young people with psychiatric illness.
Have you read this book?
Tell us what you think |
